Abstract:The purposes of this study were to clarify the expression patterns of phosphorylated mammalian target of rapamycin (p-mTOR), mTOR, and phosphatase and tensin homolog (PTEN) in primary pancreatic neuroendocrine tumors (pNETs) and their significance in predicting clinical behaviors and postoperative outcomes. The expressions of p-mTOR, mTOR, and PTEN were assessed in 20 normal pancreatic islets and in 90 resectable pNETs using immunohistochemistry. The associations of the biomarker expressions with clinicopathologic variables and survival duration were analyzed. The percentages of G1, G2, and G3 tumors were 54.4, 43.3, and 2.2 %, respectively. A strongly positive staining was observed for both mTOR and PTEN in normal pancreatic islets, whereas negative staining was observed for p-mTOR. In primary pNETs, the mTOR and p-mTOR positive rates were 70.8 % (63/89) and 44.4 % (40/90), respectively. p-mTOR expressions strongly correlate with mTOR expressions. No significant correlation between p-mTOR and clinicopathological features was found. The high expression rate of PTEN was 56.7 % (51/90), whereas the low expression rate was 43.4 % (39/90). PTEN loss (low expression) was significantly more frequent in patients with advanced WHO grades (p = 0.004) and in patients with higher Ki-67 index (p = 0.002). In our immunohistochemical classification system, the Ki-67 index was significantly higher in the PTEN low expression/p-mTOR-positive subgroup (2.7 ± 2.5) than in the PTEN high expression/p-mTOR-negative subgroup (1.0 ± 1.7, p = 0.006). Patients in the PTEN low expression/p-mTOR-positive subgroup presented a significantly lower 5-year overall survival (OS) than those in the PTEN high expression/p-mTOR-negative subgroup (p = 0.049; 5-year OS = 79 vs. 100 %, HR = 7.0). ENETS TNM staging and major vascular invasion were independently associated factors for predicting the overall survival rate of patients (p = 0.019 and 0.011, respectively). In conclusion, positive p-mTOR expression and PTEN loss may have a synergic effect on tumorigenesis and proliferation; targeted therapy based on mTOR/PTEN signal pathway and its associated molecular mechanism may play a role in the treatment of pancreatic neuroendocrine tumors.

Correlation Between Protein Expression of PTEN in Human Pancreatic Cancer and the Proliferation, Infiltration, Metastasis and Prognosis

The Clinical Significance of PTEN Protein Expression in Colorectal Carcinoma

The Study of Expression and Significance of PTEN in Tissues of Human Pancreatic Carcinoma

[Correlation Between the PTEN/MMAC1/TEP1 Expression and Cell Proliferation and Apoptosis in Human Renal Cell Carcinoma (RCC)].

Clinical significance of PTEN and B7-H1 expressions in pancreatic carcinoma

Expression of PTEN Protein and the Clinical Value of the Expression in Primary Breast Carcinoma

Clinical Value of the Expression of PTEN Gene,Progesterone Receptor and Estrogen Receptor for Predicting Biological Behaviors and Prognosis of Breast Carcinoma

Expression of PTEN Protein in Gastric Carcinoma, Adjacent Mucosa and Precancerous Lesions of Stomach and Its Significance

EXPRESSION OF PTEN GENE IN HUMAN HEPATOCELLULAR CARCINOMA AND ITS CLINICAL SIGNIFICANCE

Study on Breast Cancer PTEN Protein Expression and Matrix Metalloproteinase-9 Expression Correlation and Its Clinical Significance

Relation Between PTEN Expression and Clinicopathological Characteristics of Colorectal Carcinoma

Expression of Pten and Mtor in Pancreatic Neuroendocrine Tumors

Expression of PTEN in Prostate Cancer and Its Clinical Significance

Expression and the Correlation Between PPARγ and PTEN Protein in Human Breast Cancer

Pleiotrophin Expression in Human Pancreatic Cancer and Its Correlation with Clinicopathological Features, Perineural Invasion, and Prognosis

Loss of PTEN Expression in Breast Cancer: Association with Clinicopathological Characteristics and Prognosis

Clinicopathological significance of PTEN protein expression in breast cancer:a Meta-analysis

PTEN Protein Expression and the Relationship Between Prostate Cancer Patho-Staging

Expression of PTEN Gene in Cervical Cancer and Its Relationship with Prognosis

Expression of PTEN in hepatocellular carcinoma and its relationship with p53, cell proliferation and apoptosis

Clinical Significance of the Expressions of PTEN and P-Akt Proteins in Gastric Carcinoma and Its Relationship to Prognosis